Abstract-Several cardiotonic agents (MCI-154, sulmazole, pimobendan and adibendan) were examined for their ability to influence Ca2+-activated tension development and MgATP-activated tension development in the absence of free Ca2+ (rigor tension), using the chemically skinned fiber from guinea pig papillary muscles. MCI-154, sulmazole, pimobendan and adibendan all increased the tension development induced by pCa (-log[Ca2+]M) 5.8 in a concentration dependent manner (10-6 to 10-4 M). The order of the potency was as follows: MCI-1 54>pimobendan>adibendan>sulmazole.
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MCI-154 enhanced the maximum tension developed at pCa 4.4 but sulmazole, pimobendan and adibendan did not enhance it. MCI-154, but not sulmazole, pimobendan and adibendan, enhanced the tension development induced by pMgATP (-log[MgATP]M) 6.0 in the absence of free Ca2+. MCI-154, sulmazole, pimobendan and adibendan concentration dependently (10-7 to 10-4 M) increased the force of contraction in isolated guinea pig papillary muscles. The order of the potency was as follows: MCI-154> adibendan>pimobendan>sulmazole.
These results demonstrated that the Ca2+ sensitizing action on the contractile system may be involved in the positive inotropic action of MCI-154, sulmazole, pimobendan and adibendan, and that MCI-154 is the most potent among these drugs. Furthermore, sulmazole, pimobendan and adibendan did not enhance the interaction of actin and myosin, suggesting that the mechanism of actions of these drugs are qualitatively different from that of MCI-154.
tractile apparatus with those of other Ca2+ sensitizing agents, sulmazole, pimobendan and adibendan, using chemically skinned fiber from guinea pig papillary muscle.
Materials and Methods
Chemically skinned fiber: Papillary muscles in the right ventricles of male guinea pigs (weight, 250-350 g) were used in the present experiments.
Muscles were dissected in a Ringer's solution (see below). Then the ex ternal solution was replaced by a relaxing solution (see below). A small bundle with a diameter of about 0.1 to 0.15 mm and length of about 1 to 1.5 mm was dissected.
To obtain the skinned fiber, the small bundles were treated with the relaxing solution con taining 250 ug/ml of saponin for 30 min (8, 9). This concentration of saponin affects not only the surface membrane but also the sarcoplasmic reticulum membrane (8, 9).
The composition of the Ringer's solution was as follows: 150 mM NaCI, 2 mM KCI, 5 mM 4-(2-hydroxyethyl)-1 -piperazine ethanesulfonic acid, 2 mM CaCI2 and 5.5 mM glucose, pH 7.4. For the skinned fiber experi ments, appropriate amounts of stock solu tions, 1 M K-methanesulfonate (Ms), 0.1 M CaMs2, 0.1 M MgMs2, 0.05 M ATP-Na2 (KOH), 0.1 M ethylene glycol bis ((9 amino ethylether N, N'-tetraacet1c acid) (EGTA) (KOH) and 0.2 M piperazine-N,N'-bis (2 ethanesulfonic acid) (PIPES) (KOH) were mixed and diluted to make solutions. The total concentrations of the different chemicals needed to produce the desired free concen trations of Cat+, Mg2+ and MgATP2 were calculated on a computer by an interactive procedure to solve the binding equations that use the stability constants described by Smith and Martell (10, 11). The following relaxing solution was used: 129 mM KMs, 5.1 mM MgMs2, 4.2 mM ATP-Na2, 2 mM EGTA and 20 mM PIPES, brought to pH 7.0 with KOH. The concentration of EGTA was altered when necessary. In Cat+-containing solutions, 10 mM EGTA was used and specified amounts of CaMs2 were added. The force-producing capacity of the muscle preparation was in vestigated at varying free Ca2+ concentrations, a MgATP2 concentration of 3.5 mM and a free Mg2+ concentration of 1.5 mM. In all of the above alterations from the normal relaxing solution, the ionic strength was kept constant (0.2 M) by adjusting the concentration of KMs.
Very low MgATP2 was needed in some experiments (Mg-ATP activation-tension), the achievement of which with the previously described buffer system would have required total ATP in the micromolar range. The myoplasmic ATP would have been uncertain because of the hydrolysis of ATP within the skinned fiber. This hydolysis could have resulted in a gradient between the concen trations of ATP in the perfusion medium and in the center of the skinned fiber (12) . To avoid this problem, total ATP below 1.0 mM was not used. Instead, low free Mg2+ and MgATP2 were obtained by replacing EGTA with EDTA. The strongly chelates both Mg2+ and Cat+. The apparent stability constants at pH 7.0 were also taken from Martell and Smith (13): Ca-EDTA, 2.4X10-7 M, Mg-EDTA, 2.3X10-5 M. The solutions contained 3 mM ATP (total) and a fixed amount (5 mM) of free EDTA. The concentrations of total Mg and added Mg EDTA necessary to obtain the desired pMg ATP and pMg were calculated as the de scribed above.
Saponin was dissolved in the relaxing solution shortly before each experiment.
Isolated guinea pig papillary muscles: Male guinea pigs, weighing 250-350 g, were killed by a sharp blow on the skull. Right ventricular papillary muscles were rapidly excised from the isolated hearts and mounted in an organ bath (30 ml). The bath solution was a Krebs Henseleit solution of the following composi tion: 118 mM NaCI, 24 mM NaHCO3, 4.8 mM KCI, 1.2 mM KH2PO4, 2.5 mM CaCI2, 1.2 mM MgSO4 and 11 mM glucose. The solution was bubbled with 95% 02-5% CO2 at a temper ature of 32 °C. Muscles were stretched to a resting tension of about 0.5 g and stimulated with pulses of a voltage about 20% above the threshold at a frequency of 1 Hz. During the equilibration period of 1 hr, the resting tension of the muscle was adjusted so as to give the maximal contractile force. Force of contrac tion was recorded on a thermal pen writing oscillograph (NEC Sanei Instruments, Ltd., Tokyo, Japan, Recti-Horiz-8) by the use of force displacement transducers (Nihon Kohden FD Pick up, TB-612T, Tokyo, Japan). In order to eliminate the interindividual variability in the maximum inotropic response to cardiotonic drugs used in the present ex periments, isoproterenol was used as a standard. The maximal response to isopro terenol was determined at the end of each ex periment after washout of all other drugs. The concentration of isoproterenol was increased (usually up to 10-5 M) until the maximum re sponse was obtained. The inotropic effect of drugs used in the present study is expressed as the percentage of the maximal response to isoproterenol determined in the same muscle.
Drugs: All the chemicals used were reagent grade. Saponin was obtained from NBC (Cleveland, Ohio, U.S.A.). MCI-154, sul mazole, pimobendan and adibendan were synthetized at our Research Center. MCI-154, sulmazole and adibendan were dissolved in distilled water, and pimobendan was dis solved in dimethylsulfoxide.
In the skinned fiber experiments, the volume of drug solution added to the 495 /,,I bath was 5 /cl. In the isolated cardiac muscle experiments, the volume added to the 30 ml bath was 300 /tl.
Results

Skinned fiber experiments:
Skinned fiber from the guinea pig papillary muscle was pre contracted with pCa 5.8, which was a sub maximal activation ranging from 30 to 35% of the maximal response to Cat'. After addition of MCI-154, a concentration-dependent in crease in tension development was observed in the concentration range of 10-6 to 10-4 M ( Figs. 1 and 2 ). The maximal increases in tension development by 10-4 M MCI-154 amounted to 116±25% (n=8) (Fig. 2) . Pimobendan, adibendan and sulmazole also increased the pCa 5.8-induced tension de velopement in a concentration-dependent manner (10-6 to 10-4 M) (Figs. 1 and 2) . The maximal increases in the tension development after pimobendan, adibendan and sulmazole amounted to 43:L1% (n=7), 37.7±7% (n=7) and 2014% (n=7), respectively. When com pared in the concentrations producing 20% increase in the tension development at pCa 5.8, MCI-154 was about 10, 15 and 85 times more potent than pimobendan, adibendan and sulmazole, respectively.
As shown in Fig. 3 , only MCI-154 en hanced the maximum tension developed at Data are expressed as % of the pre-drug value. Means±S.E. are given; n=6-8 for MCI-1 54, 7 for sulmazole, adibendan and pimobendan. (Fig. 3) . On the other hand, sulmazole, pimobendan and adibendan had no effect on the tension development induced by pCa 4.4 (Fig. 3) .
We have previously described that in the absence of free Cat', a bell-shaped curve of tension as a function of pMgATP was ob tained in the skinned cardiac fiber from guinea pig papillary muscles (6). The maximum tension activated by MgATP (pMgATP=6.0) was 42.0±1.8% (mean±S.E.) of the maximal tension activated by pCa 4.4 that was ob tained at 3.5 mM MgATP. Because the maxi mum tension was observed at [MgATP2-] 10-6 M, the effects of cardiotonic agents on the tension development induced by pMgATP 6.0 in the absence of free Ca2+ was inves tigated in the present experiments. MCI-154 enhanced the MgATP-induced tension de velopment in a concentration -dependent manner (10-6 to 10-4 M) (Figs. 4 and 5) . On the other hand, sulmazole, pimobendan and adibendan did not affect the MgATP-induced tension development at all (Fig. 4) .
Isolated cardiac muscle preparations: The concentration-response curve for the positive inotropic effect of MCI-154 in isolated guinea pig papillary muscles is shown in Fig. 6 . The force of contraction was increased by MCI 154 in a concentration-dependent manner (10-7 to 10-4 M). For comparison, the con tractile responses to pimobendan, adibendan and sulmazole are also presented in Fig. 6 . When compared in the concentrations in Means+S.E. are given, n=5.
ducing the positive inotropic response cor responding to about 20% of the maximum response to isoproterenol, MCI-154 was about 15, 50 and 100 times more potent than adibendan, pimobendan and sulmazole, respectively.
Discussion
In the present study, we have found that MCI-154 markedly enhanced the Ca2+-ac tivated contraction of the skinned cardiac muscle fibers in comparison with sulmazole, pimobendan and adibendan. In this respect, MCI-154 was about 10, 15 and 85 times more potent than pimobendan, adibendan and sulmazole, respectively, which have been re ported to produce an increase in Ca2+ sensi tivity of the myocardial contractile apparatus (1, 2, 7) . The present study has confirmed that MCI-1 54 is the only positive intoropic agent which can enhance the interaction between actin and myosin, because this drug enhanced the maximum tension developed at a Ca2+ ion concentration giving a saturating effect (pCa 4.4) and augmented the tension development induced by MgATP in the absence of free Ca2+ (6). Unlike MCI-154, sulmazole, pimobendan and adibendan had no such effects. Since sulmazole has been found to increase Ca2+ binding to troponin (14) , the Ca2+ sensitizing effect of this drug and probably also pimo bendan and adibendan may be mainly due to an increased affinity of troponin C for Ca2} in the presence of the drugs. MCI-154 also stimulates the Ca2+ binding to troponin purified from the canine ventricular muscles and increases the activity of the myofibrillar and reconstituted actomyosin ATPases (15) . Therefore the increase in response of the contractile system to Ca2+ induced by MCI 1 54 could be due to both an increase in the affinity of troponin C for Ca2+ and a facilitation of the actin-myosin interaction. This indicates that the effects of MCI-154 on the skinned fiber preparations are qualitatively different from those of sulmazole, pimobendan and adibendan. The present findings are in agree ment with those of Perreault et al., (16) , who revealed that MCI-154 (10-6 to 10-4 M) enhanced both the sensitivity of the myofila ment to Ca2+ and pCa 4.5-induced maximum developed tension in chemically skinned fibers from ferret and human hearts. There fore, the enhancement by MCI-154 of the responsiveness of the contractile system to Ca2+ seems to be independent of the species. ). Basal force of contraction and maximal response to isoproterenol in each group were as follows: 0.35±0.5 g and 1.27±0.16 g in muscles to which MCI-154 was administered, 0.41 ±0.10 g and 1.05±0.10 g in muscles to which sulmazole was administered, 0.35±0.10 g and 1.13±0.18 g in muscles to which adibendan was administered, and 0.53±0.10 g and 1.85±0.52 g in muscles to which pimobendan was administered. Means±S.E. are given; n=7 for MCI-154, n=6 for sulmazole, adibendan and pimobendan. malian hearts at a concentration (<10-4) lower than that needed for Cat+-sensitization. In contrast, the positive inotropic effect of MCI-154 was not significantly affected by carbachol (23) , which has been reported to inhibit the cyclic AMP-mediated action of positive inotropic drugs (24) . MCI-154 scare cely increases cyclic AMP levels in the canine ventricular muscles in concentrations pro ducing definite positive inotropic effects (10-7 to 10-4 M) and increase it only at higher concentrations (>10-4 M) (23) . The positive inotropic effect of MCI-154 is not modified by a and Q-adrenergic, muscarinic and his tamine (H1 and H2) receptors or channel an tagonists (25) (26) (27) . Unlike cardiac glycosides, MCI-154 does not inhibit Na+,K+-ATPase (25) . Taken together, these results suggest that the increased Ca2+ sensitivity of the myocardial contractile system may be re sponsible for the cyclic AMP-independent action of MCI-154. However, other mecha nisms that increase intracellular free Ca2+ have not been excluded, and such a mechanism can be expected (28, 29) , since the com pound has been shown to inhibit the cyclic AMP phosphodiesterase (23) . It has been well-established that classical positive inotropic agents such as cardiac glycosides and catecholamines act through a final common pathway, i.e., an increase in the amount of Ca2+ avaiable for activation of the contractile system, and therefore all bear a potential risk of Ca2+ overload induced by drugs. The Ca2+ overload and accompanying cardiac necrosis may cause the reduction in survival time in chronic heart failure. There fore, the clinical treatment for heart failure with positive inotropic agents should be most safe if cardiotonics that do not increase the intracellular Ca2+ concentration could be used. Interestingly, Colucci et al. (30) have also suggested that the ideal positive inotro pic agent may be one whose sole action is to increase the sensitivity of the contractile system to Ca2+ ions. In this context, the in troduction of a Ca2 sensitizing agent such as MCI-154 may stimulate the development of newer cardiotonic agents.
In conclusion, the present study has shown that the Ca2+-sensitizing action on the con tractile system may be involved in the positive inotropic effects of MCI-154, sulmazole, pimobendan and adibendan, and MCI-154 is the most potent among these drugs. Furthermore, sulmazole, pimobendan and adibendan did not enhance the interaction between actin and myosin, suggesting that the mechanism of action of these drugs are qualitatively different from that of MCI-154.
